All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
Syndicated LoansInvestment Grade Loans

Lonza loads up $5.5bn funding for Capsugel buy


Swiss pharmaceutical and biotech ingredients supplier Lonza has secured $5.5bn in funds from Bank of America Merrill Lynch and UBS for the acquisition of US dosage form maker Capsugel, in a financing package that includes a variety of debt and equity products.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree